Clearwater agrees to buy investment management platform Enfusion for $1.5B

1. Clearwater to acquire Enfusion for $1.5 billion, enhancing investment management tools. 2. The deal includes $800 million loan and significant stock issuance to Enfusion shareholders. 3. Clearwater expects $201 million revenue and $210 million recurring revenue from Enfusion. 4. Deal expected to close in Q2 2025, pending shareholder and regulatory approval. 5. Acquisition positions Clearwater to enter new geographies and hedge fund market.